Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 247 results for "biotechnology regulatory authority of..."

Nutra Pharma Announces Nyloxin(R) Acceptance by Chinese Medica...

Nutra Pharma Has Announced That They Have Received Notification of the Acceptance of Nyloxin(R) by the China International Exchange and Promotive Association for Medical and Healthcare (CPAM) CORAL SPRINGS, FL -- (Marketwired) -- 04/30/15 -- ... Securities Technology Monitor, 6 days ago
[x]  

Banking Newsletter - March 16 to 20, 2015

Top Stories India prepared for impact of Fed policy shift: Rajan RBI governor Raghuram Rajan expects volatility in the Indian financial market if US Federal Reserve raises interest rate, according to a media report. India is well prepared to ...
 India Infoline1 month ago

Biocon top line grows 15% in Q4 FY15; Research Services delivers 27% growth; FY15 Revenues at Rs. 3143 Crore, PAT at Rs. 497 Crore

Comments April 30, 2015 - Bangalore, Karnataka, India Business Wire India Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, announced its Q4 and FY 15 financial results on April 29, 2015. Commenting on the ...
 AndhraNews.net5 days ago
Broadway World

ICON by Industry Thought Leaders is Released

ICON plc (ICLR), a global provider of drug and development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the release of the book "Re-Engineering Clinical Trials" (ISBN: 9780124202467), ...
 Broadway World3 weeks ago New Book by Industry Thought Leaders Advocates for Re-Engineering Clinical Trials  PharmiWeb3 weeks ago ICON : New Book by industry Thought Leaders Advocates for Re-Engineering Clinical Trials  4 Traders3 weeks ago
[x]  

Strand Life Sciences Names To Expanded Leadership Position Of Global President And Introduces U.S. Management Team

U.S. Team Focused on National Launch of StrandAdvantage, Company's Pan-Cancer Genomic Profiling Service BANGALORE, India and AURORA, Colo., April 15, 2015 /PRNewswire/ -- Strand Life Sciences, a global genomic profiling company that uses next ...
 BioSpace3 weeks ago Strand Life Sciences Names Scott Storrer to Expanded Leadership Position of Global President and Introduces U.S. Management Team  BioSpace3 weeks ago Strand Life Sciences Appoints Scott Storrer as Global President  EHealth Magazine2 weeks ago STRAND LIFE SCIENCES : Names Scott Storrer to Expanded Leadership Position of Global President and Introduces U.S. Management Team  4 Traders3 weeks ago
[x]  

Half Yearly Report

RNS Press Release 26 March 2015 Interim Results to 31 December 2014 Epistem Holdings Plc (LSE: EHP), the biotechnology and personalised medicine company, announces today its unaudited interim results for the six months to 31 December 2014. The ...
 MoneyAM1 month ago EpiStem : Half Yearly Report  4 Traders1 month ago Epistem Holdings plc Half Yearly Report  ADVFN UK1 month ago

IPO Report: aTYR PHARMA (LIFE)

aTYR PHARMA (LIFE) engages in the discovery and clinical development of innovative medicines for patients suffering from severe, rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators. It is ...
 Equities.com1 hour ago

Soligenix, Inc. (SNGX: OTCQB) | Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO

/PRNewswire/ --Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it will ...
 Pink Sheets2 days ago Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO  Market Pulse Navigator2 days ago INTREXON : Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO  4 Traders2 days ago
[x]  

Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175

Abstract Background A phase I randomised, controlled, single blind, dose escalation trial was conducted to evaluate safety and immunogenicity of JAIVAC-1, a recombinant blood stage vaccine candidate against Plasmodium falciparum malaria, composed ...
 Plosone.org6 days ago

Regenerative Medicine: Global Trends, Estimates and Forecasts, 2013-2019

Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017, growing at a CAGR of 12.2% for the analysis period 2013-2019 respectively.
 Global Information Inc1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biotechnology regulatory authority of india b
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less